Source: Eur Respir J 2007; 30: 496-500
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Hernandez C., Abreu J., Abreu P., Castro A., Jimenez A.. Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP. Eur Respir J 2007; 30: 496-500

Member's Comments

No comment yet.

Related content which might interest you: Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment Source: Eur Respir J 2003; 22: 251-257 Year: 2003 Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 The influence of 3-weeks‘ therapy of continous positive airway pressure (CPAP) on serum leptin and homocysteine concentration in patients with obstructive sleep apnea (OSA) Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 The effect of theophylline and CPAP on cytokine release in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 216s Year: 2006 CPAP decreases plasma levels of soluble tumour necrosis factor-α receptor 1 in obstructive sleep apnoea Source: Eur Respir J 2008; 32: 1009-1015 Year: 2008 Relationship between aldosterone and the metabolic syndrome in patients with obstructive sleep apnea: Effect of continuous positive airway pressure treatment Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013 Plasma endothelin-1 (ET-1) levels in obstructive sleep apnea (OSA) patients and effect of continouous positive airway pressure (CPAP) treatment Source: Eur Respir J 2005; 26: Suppl. 49, 40s Year: 2005 Effects of nasal continuous positive airway pressure treatment on C-reactive protein in patients with obstructive sleep apnea Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009 Effect of continuous positive airway pressure treatment on elevated levels of C-reactive protein in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 330s Year: 2004 Serum vitamin D levels in patients with obstructive sleep apnea syndrome and concentration changes after continuous positive airway pressure treatment Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects Year: 2020 Effects of autoCPAP treatment for obstructive sleep apnea on 24-hour blood pressure and nocturnal catecholamines Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009 Efficacy of daytime continuous positive airway pressure titration in severe obstructive sleep apnoea Source: Eur Respir J 2001; 18: 535-541 Year: 2001 Treatment with CPAP reduces mortality in patients with obstructive sleep apnoea syndrome within less than 3 years Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea Year: 2006 Serotonin in obstructive sleep apnea patients with before and after the continuous positive airway pressure treatment Source: Annual Congress 2005 - Upper airway interventions in OSA patients Year: 2005 Continuous positive airway pressure in patients with obstructive sleep apnea: Age-dependent adherence Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010 Cardiac sympathovagal balance during sleep in obstructive sleep apnea patients is different under auto-adjusting CPAP than fixed-CPAP treatment Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea Year: 2006 Effect of continuous positive airway pressure treatment (CPAP) in angiogenic growth factors‘ expression in patients with COPD and obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 Effects of continuous positive airway pressure (CPAP) on quality of life in patients with obstructive sleep apnea syndromes (OSAS) Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010 Effect of 8 week CPAP therapy on insulin resistance, serum leptin and lipid concentrations among obstructive sleep apnea hypopnea syndrome (OSAS) patients Source: Eur Respir J 2004; 24: Suppl. 48, 330s Year: 2004 Is the daily duration of nasal CPAP ventilation the main determinant of improvement of blood gases in OSAS (obstructive sleep apnoea syndrome) patients? Source: Eur Respir J 2001; 18: Suppl. 33, 390s Year: 2001